ARTICLE | Distillery Therapeutics
Inflammation
April 25, 2017 3:59 PM UTC
In vitro and mouse studies identified a pyridine-based inhibitor of FOXM1 that could help treat asthma. Screening of a small molecule library in cell-based assays identified a cyanodithienopyridine an...
BCIQ Company Profiles
BCIQ Target Profiles